ABSTRACT. It has been proposed that the high serum myoinositol promotes fetal growth and affects development of lung surfactant. However, it is unclear how the extracellular myoinositol becomes available in specific cells and whether &ere are developmental differences in myoinositol uptake. In the present study the mechanisms and perinatai development of intracellular myoinositol uptake into rabbit lung cells were investigated. Lung slices, lung explants, and type I1 alveolar cells were used. Evidence of saturable, sodium-and energy-dependent, and of non-saturable, sodium-and energy-independent myoinositol uptake was found. The nonsaturable uptake decreased by 67% during spontaneous maturation, as studied in lung slices. Betamethasone (0.2 mg/kg days 26.3 and 27.3, to the doe) decreased by 65% the nonsaturable myoinositol uptake in 28-day-old fetuses. However, the saturable uptake revealed only small changes during perinatal development. The effect of extracellular myoinositol on surfactant phospholipid synthesis was evaluated in lung explants from 28-day-old fetuses, cultured for 2 days. In the presence of M dexamethasone the concentration of extracellular myoinositol, required for half-maximal inhibition of surfactant phosphatidylglycerol incorporation was higher than in explants grown without the hormone (approximately 0.4 versus 0.2 mM). However, in the microsomal fraction the phosphatidylglycerol incorporation was always inhibited by as low as 4 pM myoinositol. Myoinositol was taken up by isolated type I1 cells preferably by nonsaturable mechanism. The -ihosphatidylglycerol incorporation was less sensitive to extracellular mvoinositol in adult than in fetal cells. Although there were bnly small changes in the concentration of free myoinositol in whole lung during perinatal development, the availability of this sugar alcohol to some specific cells decreased strikingly due to a decrease in serum concentration and a decrease in permeability of this putative growth factor. The present findings demonstrate that some cells within myoinositol-rich tissue can be devoid of this sugar alcohol and critically depend on extracellular source for their myoinositol supply. (Pediatr Res 20: 179-185, 1986) 
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Myoinositol is incorporated into phosphoinositides, and in kidney it is also oxidized into glucuronic acid (14) . Myoinositol pools within a number of tissues undergo a rapid turnover as a result of specific stimuli, for instance nerve impulse transmission, hormone secretion, or mitogenic stimulus (15) . The enhanced myoinositol turnover, as an early postreceptor event involves hydrolysis of phosphoinositide (resulting in a change in membrane characteristics) and a subsequent incorporation into phosphoinositide. However, the concentration of myoinositol in individual cells may not be uniform (16) and a given myoinositol pool within the tissue may not be associated with postreceptor events involving enhanced turnover (17) .
In type I1 alveolar cells (6, 18) and in some extrapulmonary cells (19) there is a reciprocal relationship between the synthesis of PI and PG, possibly because myoinositol stimulates PI synthesis, and thereby depletes the rate limiting substrate, CDPdiacylglycerol, required for PG (4) . This concept implies that the availability of myoinositol in type I1 cells affects the concentration of individual acidic phospholipids. Indeed surfactant P1 and PG appear successively and serum levels of myoinositol decrease concomitant with perinatal lung maturation (20) (21) (22) .
In the present investigation the relationship between extracellular myoinositol, pulmonary myoinositol uptake, and between myoinositol-sensitive phospholipid incorporation has been evaluated.
MATERIALS AND METHODS
New Zealand White rabbits were used. The animals received 30-45 mg/kg Ketamine HCl (Parke-Davis, Detroit, MI) and 10-15 mg/kg Xylazine (Haver-Lochart, Shawnee, KS). In addition, 0.25% lidocaine was used in local anesthesia. The fetuses were sacrificed by intracerebral thiopental sodium (10 mg) through uterine wall, and subsequently bled through the abdominal aorta. PG, phosphatidylglycerol
The isotopes were purchased from New England Nuclear PI, phosphatidylinositol (Boston, MA). CDP-diacylglycerol (egg lecithin derivative, from MEM, minimal essential medium with Hanks' salts Serdary Research Laboratories, London, Ontario, Canada) was further purified as described previously (23) .
trimmed to a weight range of 35 to 45 mg. A slice was transferred to 3 ml of Krebs-Ringer phosphate medium containing 2% (w/ v) defatted bovine serum albumin (pH 7.4), and incubated for 15 rnin with gentle agitation at 37" C. Thereafter the slices were dried and transferred to gas tight vials containing 1 ml of KrebsRinger bicarbonate supplemented with 5 m M glucose and 2% bovine serum albumin (pH 7.4), in 95% 0. and 5% C0,. The incubation medium additionally contained [2-'H]myoinositol (spec. act. 4 to 140 FCi/pmol) and 10 pM [14C]mannitol (spec. act. 40 pCi/pmol). The slices were incubated for 15 rnin at 37" C, unless otherwise indicated. The composition of the preincubation and incubation media, as well as the incubation time were often modified, as indicated in "Results." After the incubation, the slices were dried, weighed, transferred to Millipore filters, washed with Krebs-Ringer phosphate, and homogenized in icecold 0.5 M perchloric acid. The homogenate was centrifuged at 5000 x g for 10 min. The supernatant was counted for radioactivity using the channel ratio method. The radioactive myoinositol, taken up to the intracellular space, was calculated as follows:
During each experiment the intracellular water was measured as the difference between total lung water and extracellular water (=mannit01 space). The total tissue water was the weight difference between the fresh and freeze dried lung. The mannitol space was obtained by incubating the lung slices, as described above, in the presence of 10 FM E~peritncnl.~ with orgun allture. The lungs were obtained from 28-day-old fetuses. The organ culture system was a modification of that described by Gross et ul. (24) and others (3) . The lungs were chopped into 0.3 to 0.8 mm' cubes. Twenty (labeling experiments) or 40 (isolation of microsomes and mitochondria) explants were placed on a culture dish, diameter 35 mm. The sterile culture medium, 0.6 ml to each dish, contained the MEM (from K.C. Biological. Lenexa, KA), 100 U/ml penicillin and 100 Fg/rnl streptomycin. When indicated the culture medium additionally contained 10-% dexamethasone and/or extra myoinositol. The explants were cultured at 37" C in a humidified atmosphere containing 20% 0. and 5% CO,. The culture chamber (Bellco Glass, Inc., Vineland, NJ) rotated at a rate of 9 cycles/ rnin (Rotating Platform, Heidolph, West Germany), allowing the explants to be cyclically exposed to the culture medium and to the atmosphere. After 3 days in culture a vast majority of the cells were well preserved and excluded the vital dye. Type I1 cells were predominant alveolar epithelial cells, as demonstrated by electron microscopy.
For studies of the incorporation of the label into phospholipids a ncw medium was added after 48 h in culture. This was identical to the previous medium except that it contained 0.25 m M [I-lT]sodium acetate (10 pCilPmol), and when indicated extra myoinositol, as shown in "Results." After the incubation with the radioactive isotope for 16 h, the medium was removed. Thereafter the explants were recovered and the lamellar body and the mitochondrial fractions were isolated as described previously (3). The radioactivity associated with saturated phosphatidylcholine (25, 26) , PG, PI, phosphatidylcholine, sphingomyelin, and phosphotidylethanolamine was analyzed as described earlicr (23) .
The microsomal and mitochondrial fraction were isolated as described previously (23) . The wet weight of the starting material was 0.5-0.8 g (25-40 dishes). The recovery of the microsomes (1.0 + 0.3 mg/g wet weight) and mitochondria (1.2 + 0.4 mg/g wet weight) was similar in the hormone exposed and the control lungs. Succinate cytochrome C reductase and NADPH cytochrome C reductase activities were measured in mitochondria and microsomes (23) . On the basis of these assays there was 12% mitochondrial protein contamination in the microsomal fraction and 12% microsomal contamination in the mitochondrial fraction.
The effect of myoinositol on ["C]glycerol 3-PO, incorporation into P C and phosphatidylglycerolphosphate was studied using mitochondria and microsomes (4) . Forty microliters of the incubation mixture containing 30 FM CDP-diacylglycerol, 6 mM reduced glutathione, 5 m M MnCI2, 0.5 m M glycerol 3-PO, (52 pCi/pmol), 100 mM Tris-HC1, 60 fig protein (microsomes or mitochondria), myoinositol, and when indicated 2 m M CMP. CDP-diacylglycerol was first added to the conical tube. The enzyme and MnCl?, in that order were added last, followed by mixing with a Vortex. The incubation took place for 15 rnin at 37" C with continuous agitation. After the incubation, the lipid radioactivity was measured (23) .
Isolation and experiments with type II cells. Type I1 cells were isolated from the lungs of adult and 30-day-old fetal rabbits essentially according to Mason et ul. (27) with several modifications. Young male rabbits (weighing) 1 .O-1.2 kg received 4000 U of sodium heparin intraperitoneally and were bled through the carotid artery. The pulmonary vessels were perfused through a catheter placed in the pulmonary artery, until the lungs appeared bloodless. The perfusion medium contained 135 m M NaCI, 4 mM KC1, 2.0 m M sodium phosphate, 10 m M HEPES, 5 m M glucose, 100 U/ml penicillin 100 Fg/ml streptomycin, pH 7.4 (medium 1). The trachea was cannulated and the airways were lavaged five times by introducing and withdrawing about 15 ml/kg body wt of sterile isotonic saline, in order to remove macrophages. The fetuses received 200 U heparin intraperitoneally. The lungs were perfused through a catheter in the pulmonary artery, distal to the ductus arteriosus.
Large airways were removed and the tissue was minced until the final size of the pieces was about 1 mm3. Any remaining blood and cell debris was removed by washing with 135 m M NaC1, 4 m M KC1, 2.0 m M sodium phosphate, 1.7 m M CaCI, 1 m M MgSO,, 10 m M HEPES, 5 m M glucose, 100 U/ml penicillin, 100 Fg/ml streptomycin, pH 7.4 (medium 11). Thereafter medium 11, that contained 3 mg/ml of trypsin, 30 Fg/ml DNA:se (Sigma), was added (10 ml/g tissue). The dispersion was incubated for 35 min in a reciprocating water bath at 60 cycles/min at 37" C. Thereafter 1.5 ml of fetal calf serum/g of lung was (28) . The culture medium contained MEM, 100 U penicillin/ ml, 100 wg streptom)cin/ml, and 10% (v/v) serum from adult rabbit. More than 90% of the cells that adhered to the culture dish during 20 h excluded the vital dye, erythrocin B (29) . Electron microscopy revealed that 75-85% of the cells were type I1 alveolar cells. In order to study myoinositol uptake, the cells that were adherent to the dish during 20 h in culture, were detached from the surface of the flask by rubber policeman. Together 2-3 X 10" cells were suspended to 1 ml of serum-free MEM, that contained [2-'H]myoinositol and 10 pM [14C]mannitol. The suspension was incubated with gentle agitation for 15 min at 37" C in 95% 02-5% COz atmosphere. After the incubation the suspension was washed on millipore filters (0.22 pm), and the radioactivity associated with the filter was counted. The intracellular myoinositol uptakc was calculated as the amount of [3H]myoinositol minus the amount of [14C]mannitol that was present in the filter (see "Methods": myoinositol uptake).
The incorporation of [I4C]acetate into phospholipids of type I1 cells was studied as follows. After the differential adherence the type I1 cells were further cultured in MEM containing 0.5 mM [l-14C]sodium acetate and a known amount of myoinositol for 20 h. Thereafter, the medium was removed and the cells were detached using a rubber policeman. Subsequently the phospholipid-associated radioactivity was analyzed in the media and the cells. Other methods. Myoinositol was measured as the trimethylsilyl derivative using gas liquid chromatography as described previously (21) . The results were expressed as means + SE. The statistical significance was calculated using the two-tailed t test.
RESULTS
Myoinositol uptake into the lung slices. Neither the age nor the glucocorticoid treatment significantly affected the intracellular water, expressed as percentage of the fresh weight of the lung. Therefore, the myoinositol uptake was expressed on the basis of the fresh weight of the tissue.
In preliminary studies the lung slices were obtained from 28-day-old fetuses and from adults. The myoinositol uptake was linear during 30 min of incubation in the presence of 10 FM myoinositol. Ouabain, Li' (instead of Na'), and sodium cyanide decreased myoinositol uptake (Table 1) . The percentage inhibition was always higher in the presence of 10 /*M, instead of 2 mM myoinositol. The effects of Li' and ouabain (increased intracellular Na') were additive. Therefore, in subsequent experiments sodium independent myoinositol uptake was studied in the presence of both Li' and ouabain.
The myoinositol taken up by the lung was analyzed. Regardless of the source of the lung or the presence of myoinositol transport 182 HALLMAN ET AL.
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Since glucocorticoid increases surfactant PG (30, 31) and the synthesis of this phospholipid is sensitive to myoinositol, we studied whether the hormone exposure of the fetal lung alters the myoinositol sensitivity of [14C]acetate incorporation into PG. Figure 3 shows the effect of extracellular myoinositol on incorporation of acetate into surfactant PG, PI, and saturated phosphatidylcholine fetal lung explants in vitro. Dexamethasone increased the extracellular concentration of myoinositol that was required to inhibit PG and stimulate PI incorporation. However, the hormone treatment did not decrease the maximal inhibitory effect of myoinositol.
In order to evaluate whether the observed difference in myoinositol sensitivity of [14C]acetate incorporation into PG is due to a difference in intracellular myoinositol uptake, the PG incorporation was studied in the microsomal preparation obtained from lung explants. There was little [14C]acetate incorporation into PG in the absence of CDP-diacylglycerol (2 pmol. min-I mg-' prot.), even if 2 mM CMP was added to the mixture (6 mg-I prot.). In the presence of the CDP-diacylglycerol excess, neither 2 mM myoinositol (201 pmol.min-I .rng-l prot) nor 2 mM CMP (2 19 pmol . min-l. mg-I prot.) had a large effect on [14C]acetate incorporation into PG. Decrease in CDP-diacylglycerol concentration rendered the microsomal PG incorporation sensitive to myoinositol. Figure 4 shows the rate of [14C]glycerol 3-P incorporation into PG + phosphatidylglycerolphosphate as a function of myoinositol concentration. The microsomal PG incorporation was sensitive to myoinositol. In mitochondria the small effect of myoinositol on PG could in part be due to microsomal contamination. Under these conditions neither 2 mM CMP, nor glucocorticoid had detectable effect on PG incorporation.
Experiments with isolated type II cells. A number of different cells rather than one cell type can contribute to the results. Therefore, myoinositol uptake in type I1 alveolar cells was further studied (Fig. 5) . Cells isolated from term fetuses and young rabbits were used. The nonsaturable uptake was more prominent in type I1 cells than in the whole lung. The rate of myoinositod uptake was apparently higher in fetus than in the adult. Table 3 shows the effect of extracellular myoinositol on thle distribution of PG and PI synthesis in isolated type I1 cells. In type I1 cells from both fetuses and adults myoinositol tended to increase PI and decrease PG. In fetal cells these changes tended to take place at lower myoinositol concentration than in the adult.
DISCUSSION
In the present study we have found evidence on two mechanisms of myoinositol uptake into lung cells, namely a undirectional, sodium-and energy-dependent transport and a nonsaturable, sodium-and energy-independent uptake. The present data on the energy-dependent uptake essentially confirm the earlier findings in the lung (8) and in other tissues (9) (10) (11) (12) 32) .
The concentration that allowed half-maximal energy-dependent uptake was 75-90 rtM, i.e. similar to adult serum myoinositol and clearly less than that in the fetus. Assuming that the properties of the transport system in vitro correspond to those in vivo, the uptake is active even with relatively low serum concentration and is saturated at higher myoinositol concentrations. On the other hand, the nonsaturable, energy-dependent uptake is always directly proportional to the extracellular myoinositol concentration.
A study on myoinositol content of individual brain cells in vivo revealed that the exceptionally high myoinositol, present in central nervous system, was not a feature of all cells (16) . A similar phenomenon could occur in other organs, especially in the lung with its more than 40 different cells. It is possible that the differences in the intracellular myoinositol content are in part due to differences in intracellular uptake.
Our second aim was to correlate the extracellular myoinositol concentration with intracellular phospholipid synthesis. We have demonstrated a myoinositol-induced inhibition in PG synthesis and a corresponding increase in PI synthesis in a subcellular preparation mainly representing endoplasmic reticulum membranes. An analogous phenomenon has been demonstrated in intact lung (4) and in isolated type I1 cells (6, 18) . In the cell-free system the concentrations required for maximal inhibition of PG were at least one order of magnitude lower than those required to suppress PG in intact lung cells. It may be argued that the phenomenon taking place in cell-free preparation is essentially different from that in intact lung cells. However, the microsomal fraction that exhibited the myoinositol-sensitive PG synthesis has been pulse labeled in vivo. Its PG incorporation was also sensitive to myoinositol although the serum concentrations required for the inhibition were more than one order of magnitude higher than those in vitro. Furthermore, the in vivo labeled microsomes revealed a precursor-product relationship with the intracellular surfactant (26) . This suggests that the myoinositol-induced suppression of PG in cell-free preparation represents the same phenomenon that takes place in intact cell, although the concentrations required are different owing to differences in availability of this sugar alcohol.
It has been proposed that the saturable, energy-dependent myoinositol uptake is in part responsible for increasing its concentration at the site of the acidic surfactant phospholipid synthesis (8) . The maximal PG suppression was demonstrated first with extracellular myoinositol concentratior, that exceeded the maximum rate of the energy-dependent uptake. Furthermore, the myoinositol uptake into type I1 cells was predominantly nonsaturable (Fig. 5) . Therefore, the availability of myoinositol into the site of the acidic surfactant phospholipid synthesis may depend on the nonsaturable uptake of myoinositol.
The third aim of the present study was to find out whether the intracellular myoinositol uptake changes in activity during perinatal development. This alteration is possible, since according to current hypothesis the concentration of myoinositol in type I1 cells decrcases during maturation. There were no remarkable developmental trends in the saturable, energy-dependent uptake. However, both during spontaneous, and glucocorticoid-stimulatcd maturation there was a dccrease in the nonsaturable uptake. This could be due to a decrease in the size of myoinositolaccessible intracellular space, due to increase in intracellular myoinositol concentration, or due to decrease in permeability. The last alternative is more likely because: 1) the nonsaturable uptake decreased both in the whole lung and in type I1 cells; 2) mature lung cells or glucocorticoid-exposed fetal lung explants required a higher concentration of extracellular myoinositol for suppression of PG synthesis than the fetal lung cells or lung explants. This difference cannot be due to an age-related change in extracellular permeability, since the intracellular myoinositol uptake was corrected for the extracellular sugar uptake using [14C]mannitol or ['H]carboxyinulin as a reference. Despite this there were no detectable differences in myoinositol suppressibility of PG synthesis in a subcellular preparation of the lung. This supports the concept that during perinatal development the type I1 alveolar cells (or at least the site of surfactant phospholipid synthesis) become less permeable to myoinositol.
We propose that there is a striking decrease in the availability of myoinositol to specific lung cells during perinatal development. This is due to a decrease in the extracellular concentration and a decrease in the permability of myoinositol. These additive phenomena are in part responsible for decrease in surfactant PI and increase in PG.
Among the other mechanisms that possibly explain the increase in PG (3, 23) , it has been proposed that CMP shifts the equilibrium of CDP-diacylg1ycerol:inositol phosphatidyltransferase toward CDP-diacylglycerol (33) . This attractive hypothesis is supported by the observation that CMP content increases in developing lung possibly due to increase in surfactant phosphatidylcholine synthesis (34) . However, Batenburg et al. (6) were unable to demonstrate that a stimulated phosphatidylcholine synthesis changes the distribution between PG and PI. This may be due to myoinositol or CDP-diacylglycerol that mask the effect of CMP on synthesis of the acidic surfactant phospholipids. Under the present experimental conditions myoinositol had little effect on surfactant phosphatidylcholine synthesis (Fig. 3) , whereas there were differences in myoinositol uptake (Fig. 2 , Table 2 ). Therefore the observed differences in the myoinositol sensitivity of PG synthesis (Fig. 3, Table 3 ) were not only due to differences in intracellular CMP.
The hypothesis that myoinositol is a vitamin-like essential nutrient (35) has been disputed on the basis of the fact that in any tissue there is active synthesis (8, 20, 36) and generally high (although strictly tissue specific) intracellular concentration of this sugar alcohol (7) . However, the present findings demonstrate why some cells within myoinositol-rich tissue may have a low concentration of this sugar alcohol and depend on extracellular source for their myoinositol supply.
Conditions may exist that are associated with increased or decreased extracellular myoinositol concentration. For instance, high serum levels may promote fetal growth and differentiation (3, 35) . Maintenance of rodents on myoinositol-free diet results in intestinal lipodystrophy (37) or fatty liver (38) . On the other hand, this sugar alcohol increases the growth of some malignant cells in vitro (39) . Therefore, the causes and consequences of myoinositol "excess" and "deficiency" remain to be further elucidated.
